#151070

Anti-p13 [AA10.2]

Cat. #151070

Anti-p13 [AA10.2]

Cat. #: 151070

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: p13 (SUC1)

Class: Monoclonal

Application: IHC ; IP ; WB

Reactivity: Schizosaccharomyces pombe

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Julian Gannon

Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-p13 [AA10.2]
  • Research fields: Cell biology;Genetics
  • Clone: AA10.2
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Schizosaccharomyces pombe
  • Host: Mouse
  • Application: IHC ; IP ; WB
  • Description: p13 SUC1 is a CDK subunit from S. pombe that interacts with CDK1. p13 SUC1 is used exclusively to capture CDK1 complexes from various cell lines and egg extracts.
  • Immunogen: p13
  • Isotype: IgG1 kappa
  • Myeloma used: Sp2/0-Ag14
  • Recommended controls: Raji cells or breast carcinomas.

Target Details

  • Target: p13 (SUC1)
  • Tissue cell line specificity: Raji cells or breast carcinomas.
  • Target background: p13 SUC1 is a CDK subunit from S. pombe that interacts with CDK1. p13 SUC1 is used exclusively to capture CDK1 complexes from various cell lines and egg extracts.

Applications

  • Application: IHC ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Yang et al. 2005. J Am Soc Nephrol. 16(10):2890-6. PMID: 16107581.
  • Redistribution of myosin VI from top to base of proximal tubule microvilli during acute hypertension.
  • Gee et al. 1999. J Pathol. 189(4):514-20. PMID: 10629551.
  • Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer.
  • Batsch et al. 1998. Mol Cell Biol. 18(7):3647-58. PMID: 9632747.
  • RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.